Raleigh biotech targeting cancer raises $37M, plans to triple headcount
The Raleigh-based company will further its effort to develop cell therapy treatments targeting difficult-to-treat cancers. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 19, 2022 Category: American Health Authors: Zac Ezzone Source Type: news

Developer buys Billerica land from Cabot for biomanufacturing
The Boston-based firm intends to build a 200,000-square-foot good manufacturing practice, or GMP, plant on the property. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 19, 2022 Category: Biotechnology Authors: Greg Ryan Source Type: news

PIDC seeks partners to develop massive biotech campus on 40 acres of Schuylkill riverfront property
The campus is expected to generate more than 4,000 jobs. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 19, 2022 Category: Health Management Authors: John George Source Type: news

Grand View Health finds its new CEO in-house
Former CEO Jean Keeler, who had been with Grand View for nearly four decades, retired in October. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2022 Category: Biotechnology Authors: John George Source Type: news

Wednesday Digest: More Twitter departures; Cerebral parts ways with founder, CEO
Meanwhile, Barker Pacific Group, owner of the FiDi skyscraper One Sansome Street, is investing $20 million to bring a new bar, restaurant and private event space to the property. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 18, 2022 Category: Biotechnology Authors: Ted Andersen Source Type: news

Morrisville biotech gains 'buying power' with $35M raise
The new funding will allow Locus Biosciences to advance its clinical development and pursue mergers and acquisitions. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 18, 2022 Category: American Health Authors: Zac Ezzone Source Type: news

Sun Pharma to launch first-in-class oral lipid-lowering drug in India
The Mumbai-based drug major said one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing LDL cholesterol. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 18, 2022 Category: Pharmaceuticals Source Type: news

Mankind Pharma launches OTT platform for doctors
The company said the platform will have 20 different shows on varied subjects, a few shows include science simplified, legend inside the white coat, stitch in time, cardio Unflip, medico-legal cases in India and much more. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 18, 2022 Category: Pharmaceuticals Source Type: news

Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent
The money will predominantly be used to refinance the debt the company had taken to fund its acquisition of diagnostics chain Thyrocare last year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 17, 2022 Category: Pharmaceuticals Source Type: news

Minnesota biotech firm Vyriad raises $29.5 million for cancer-fighting viruses
Vyriad Inc., a company that's engineering cancer-killing viruses, announced Tuesday it raised $29.5 million in Series B funding. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 17, 2022 Category: Pharmaceuticals Authors: Carter Jones Source Type: news

Muscle disorder biotech to lose 39 employees, chief medical officer
Scholar Rock Holding Corp. is losing 39 employees — one-quarter of its workforce — and its chief medical officer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 17, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

OHSU's financial problems widen, with loss projected for the year
"The issues we continue to grapple with are unlike anything I ’ve ever encountered," OHSU President Danny Jacobs says. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2022 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
ROCHESTER, Minn., May 17, 2022 -- (Healthcare Sales & Marketing Network) -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced $29.5M in new funding led by Mr. Harry ... Biopharmaceuticals, Oncology, Venture Capital Vyriad, oncolytic virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2022 Category: Pharmaceuticals Source Type: news

Remix Therapeutics Closes $70 Million Series B Financing
Supports Novel Small Molecule Therapeutic Approach Designed to Reprogram RNA Processing and Modulate Gene Expression CAMBRIDGE, Mass., May 17, 2022 -- (Healthcare Sales & Marketing Network) -- Remix Therapeutics (Remix), a biotechnology company develop... Biopharmaceuticals, Venture Capital Remix Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2022 Category: Pharmaceuticals Source Type: news

Atlas-backed RNA startup Remix raises another $70M
Less than two years out of the gate, Atlas Venture spinout Remix Therapeutics has bagged another $70M to bring its RNA-targeting drugs into the clinic. The announcement comes amid a difficult funding environment for biotech companies of all shapes and sizes. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 17, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news